Neoplasm by Special Category — Trials

Neoplasm by Special Category — Trials · CancerIndex

Clinical trials

Registered studies

95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1,351–1,400 of 1,782 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06888037	Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer	not yet recruiting	Phase 2	55	Ruijin HospitalOTHER	1	Mar 21, 2025	clinicaltrials
NCT06890182	Firmonertinib Combined With Chemotherapy as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutanted NSCLC	not yet recruiting	Phase 2	31	Tianjin Medical University Cancer Institute and HospitalOTHER	0	Mar 21, 2025